Taiwan

Roche Diagnostics Taiwan

Present since 1998 | No. 1 leader in in vitro diagnostics | 50% of employees are women.

From 2018 – 2019

7,800 osteoporosis patients reached through our bone turnover markers testing | 1.38 metric tons of carbon dioxide emissions reduced, and 114 trees saved | TWD 1,133,644 raised as part of Roche’s Children’s Walk

The Healthcare Landscape in Taiwan

With a population of more than 23 million, Taiwan’s healthcare expenditure is equal to approximately 6.6% of its Gross Domestic Product (GDP). Renowned for its National Health Insurance (NHI) system, Taiwan offers direct access to healthcare institutions and professionals, and covers more than 99% of its population.

Our Contribution to Sustainability in Taiwan

Delivering patient-centric innovation: In 2019, we launched our clinical decision support solutions to help multi-disciplinary care teams navigate large volumes of complex patient data. The platform allows hospitals to facilitate the integration of data with external sources such as treatment guidelines, clinical trials and medical publications.
Access to healthcare and diagnostics: In 2018 and 2019, our approach to improving access centred on disease awareness, screening and diagnosis, with a strong focus on women’s fertility, pregnancy care, human papillomavirus (HPV) and cancer.
- Sustainable funding solutions: Osteoporosis threatens over three million people in Taiwan. Although patients have access to osteoporosis treatments, there is low follow-through on treatment plans. Bone turnover markers (BTM) testing is an effective method of increasing treatment adherence in patients with osteoporosis. However, BTM testing is not covered by the NHI. We collaborated with our partners to organise a series of educational events to inform over 250 clinicians on the clinical value of BTMs. By raising awareness among clinicians, we have reached 3,000 patients in 2018 and 4,800 patients in 2019.
Fostering a great workplace: We are committed to creating a workplace environment that supports our employees’ wellbeing and empowers them to make a positive impact on society. As a result of our efforts, we have been recognised as one of the best employers in Taiwan.
Supporting communities: As part of our annual Roche Children’s Walk, our employees raised TWD 282,600 to support underprivileged families and advance children’s education through the Taiwan Fund for Children and Families, among other initiatives.
Meeting high standards of business ethics: We adhere to the Asia Pacific Medical Technology Association Code of Ethical Conduct and provide regular trainings to ensure compliance among our employees. In 2018, we participated in the Taiwan Food and Drug Administration’s Guidelines for the Good Distribution Practice of Medical Devices Audit and were recognised for our outstanding practices.
Minimising our environmental footprint: In 2019, we donated 235 personal computers and other electronic devices, which reduced carbon dioxide (CO2) emission by 1.38 metric tons and saved 114 trees from being cut down, among other achievements.